|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2004-3-30
|
|
pubmed:abstractText |
The current controversy on the potential cardioprotective effect of naproxen prompted us to evaluate the extent and duration of platelet, monocyte, and vascular cyclooxygenase (COX) inhibition by naproxen compared with low-dose aspirin.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/11-dehydro-thromboxane B2,
http://linkedlifedata.com/resource/pubmed/chemical/2,3-dinor-6-ketoprostaglandin...,
http://linkedlifedata.com/resource/pubmed/chemical/6-Ketoprostaglandin F1 alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Aspirin,
http://linkedlifedata.com/resource/pubmed/chemical/Cardiotonic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 1,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2 Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Dinoprostone,
http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Naproxen,
http://linkedlifedata.com/resource/pubmed/chemical/PTGS1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/PTGS2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandin-Endoperoxide Synthases,
http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandins I,
http://linkedlifedata.com/resource/pubmed/chemical/Thromboxane B2
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
30
|
|
pubmed:volume |
109
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1468-71
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15037526-6-Ketoprostaglandin F1 alpha,
pubmed-meshheading:15037526-Adult,
pubmed-meshheading:15037526-Aspirin,
pubmed-meshheading:15037526-Blood Platelets,
pubmed-meshheading:15037526-Cardiotonic Agents,
pubmed-meshheading:15037526-Cross-Over Studies,
pubmed-meshheading:15037526-Cyclooxygenase 1,
pubmed-meshheading:15037526-Cyclooxygenase 2,
pubmed-meshheading:15037526-Cyclooxygenase 2 Inhibitors,
pubmed-meshheading:15037526-Cyclooxygenase Inhibitors,
pubmed-meshheading:15037526-Dinoprostone,
pubmed-meshheading:15037526-Endothelial Cells,
pubmed-meshheading:15037526-Endothelium, Vascular,
pubmed-meshheading:15037526-Female,
pubmed-meshheading:15037526-Humans,
pubmed-meshheading:15037526-Isoenzymes,
pubmed-meshheading:15037526-Male,
pubmed-meshheading:15037526-Membrane Proteins,
pubmed-meshheading:15037526-Middle Aged,
pubmed-meshheading:15037526-Monocytes,
pubmed-meshheading:15037526-Naproxen,
pubmed-meshheading:15037526-Prostaglandin-Endoperoxide Synthases,
pubmed-meshheading:15037526-Prostaglandins I,
pubmed-meshheading:15037526-Thromboxane B2
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
|
|
pubmed:affiliation |
Department of Medicine and Center of Excellence on Aging, G. d'Annunzio University, School of Medicine, and G. d'Annunzio University Foundation, Chieti, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
